Jiangxi Sanxin Medtec News

Sanxin Medical (300453) 2023 Report Review: Collection Implementation Accelerates Localization and Focus on Extending the Entire Nephrology Industry Chain

國元證券Apr 2 00:00

Sanxin Medical (300453): 2023 performance is in line with expectations, domestic substitution in the hemodialysis industry wants to accelerate

華安證券Mar 26 07:31

Sanxin Medical (300453): Exceed incentive targets and look forward to breakthroughs in new business areas

西南證券Mar 25 00:00

Sanxin Healthcare (300453): The 2023 interim results are in line with expectations, and the company continues to expand new business

華安證券Aug 10, 2023 00:00

Sanxin Healthcare (300453): Vaccine syringes affect apparent performance The vascular intervention circuit is expected to become a new growth point

西南證券Aug 9, 2023 00:00

Sanxin Medical (300453): 2022 performance is in line with expectations, the company enters the vascular intervention business

華安證券Mar 24, 2023 00:00

Sanxin Medical (300453): The 22Q4 quarter was under pressure to lay out a new circuit for vascular intervention

西南證券Mar 23, 2023 00:00

Sanxin Medical (300453): Vaccine injectors' contribution to profit elasticity, first-half year performance exceeds market expectations

華安證券Jul 31, 2022 00:00

Sanxin Medical (300453): high growth in performance in 2022 demand for vaccine syringes abroad

西南證券Jul 28, 2022 00:00

Sanxin Medical (300453): benefit from the rapid growth of overseas vaccine syringe order Q1

華安證券Apr 20, 2022 16:01

Sanxin Medical (300453): domestic replacement of hemodialysis equipment for deepening vaccine syringe contribution increment

華安證券Apr 6, 2022 21:06

Sanxin Medical (300453): Q2 is under pressure in a single quarter and is expected to improve gradually in the second half of the year.

西南證券Jul 26, 2021 00:00

Sanxin Medical (300453): the performance is in line with the expected growth momentum in the next few years.

西南證券Mar 28, 2021 00:00

Sanxin Medical (300453): the performance is in line with our expectation that the company has a broad space for medium-and long-term development.

東吳證券Mar 27, 2021 00:00

Sanxin Medical (300453): sustained and rapid growth in performance

西南證券Oct 18, 2020 00:00

Sanxin Medical (300453): the company has a broad space for medium-and long-term development.

東吳證券Oct 18, 2020 00:00

Sanxin Medical (300453): blood purification products maintain rapid growth

西南證券Sep 2, 2020 00:00

Sanxin Medical (300453): the performance exceeds the forecast limit and the blood purification business continues to grow at a high level.

東吳證券Aug 23, 2020 00:00

Sanxin Medical (300453): Q1 performance exceeds the forecast limit, blood purification business continues to grow at a high level.

西南證券Apr 23, 2020 00:00

Sanxin Healthcare (300453): Continued high growth in the layout performance of the entire hemodialysis product line can be expected

西南證券Mar 29, 2020 00:00